Limiting The Impact Of Prometheus

Law360, New York (April 18, 2012, 12:34 PM EDT) -- In the wake of the U.S. Supreme Court's decision in Prometheus,[1] some seem to believe the sky is falling on personalized medicine and other technology spaces. It has been suggested that the Supreme Court has muddled the role of 35 U.S.C. §101 (concerning patent eligible subject) matter with that of 35 U.S.C. §102 and §103 (concerning novelty). A deeper look into the Prometheus opinion and the new United States Patent and Trademark Office guidelines, however, may reveal a path for obtaining and enforcing solid claims in personalized medicine and other technology spaces....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!